Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SPF Control appears to be a brand or product name related to sun protection, likely referring to a sunscreen or topical agent designed to protect the skin from ultraviolet (UV) radiation. Sunscreens are regulated as over-the-counter (OTC) drugs in the United States and contain active ingredients such as titanium dioxide, zinc oxide, oxybenzone, avobenzone, homosalate, and octinoxate. These agents work by absorbing or reflecting UV rays to prevent sunburn and reduce the risk of skin cancer and premature aging when used as directed[1][3][5]. The mechanism of action involves either chemical absorption of UV radiation or physical blocking via mineral filters[4]. The FDA requires sunscreens with an SPF (sun protection factor) value of at least 15 for measurable protection; higher values provide greater defense against UVB rays[2][3]. There is no evidence that "SPF Control" refers to a specific pharmaceutical drug entity beyond being a sunscreen product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SPF Control.